[
    [
        {
            "time": "",
            "original_text": "巨丰午评：两类股的炒作或结束",
            "features": {
                "keywords": [
                    "巨丰",
                    "午评",
                    "炒作",
                    "结束"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "巨丰午评：两类股的炒作或结束",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[增持评级]医药生物周报：建议关注中报表现出短期防御配置低估值流通",
            "features": {
                "keywords": [
                    "医药生物",
                    "增持评级",
                    "中报",
                    "防御配置",
                    "低估值"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级]医药生物周报：建议关注中报表现出短期防御配置低估值流通",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级]医药生物行业研究周报：优选中报业绩优异标的 布局估值切换行情",
            "features": {
                "keywords": [
                    "医药生物",
                    "强于大市评级",
                    "中报",
                    "业绩优异",
                    "估值切换"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]医药生物行业研究周报：优选中报业绩优异标的 布局估值切换行情",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【医药*全铭】8月关注医药股估值切换带来的超额收益机会，推荐我武生物、长春高新等",
            "features": {
                "keywords": [
                    "医药",
                    "估值切换",
                    "超额收益",
                    "我武生物",
                    "长春高新"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药*全铭】8月关注医药股估值切换带来的超额收益机会，推荐我武生物、长春高新等",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]